Definition of Drug-Induced Cognitive Impairment in the Elderly
Jun 14, 2000 · Neuroleptic malignant syndrome is characterized by delirium, fever, autonomic dysfunction, extrapyramidal syndrome, and recent history of antipsychotic use.
Olanzapine Associated With Lower Rate of Extrapyramidal
Oct. 2, 2003 — Olanzapine was associated with the fewest patients with extrapyramidal symptoms (EPS) at six months compared with baseline, according to the results of a large …
Levetiracetam for Managing Neurologic and Psychiatric Disorders
Levetiracetam has shown its beneficial effects in a patient with Meigs' syndrome ( Table 2). [ 62 , 63 ] Yardimci et al. [ 62 ] reported a case of a 64-year-old woman with Meigs' syndrome whose ...
Positive Phase 3 Results for Antipsychotic in Schizophrenia
Jan 12, 2024 · The investigational antipsychotic KarXT is effective in reducing positive and negative symptoms of schizophrenia, with a favorable side-effect profile in the pivotal …
Treatment Considerations for Psychiatric Syndromes Associated …
This syndrome, defined by the National Cholesterol Education Program Expert Panel, is an inter-related constellation of cardiovascular disease risk factors, linked by insulin resistance, …
Is It Safe to Use "Natural" Sleep Aids While Taking ... - Medscape
Oct 23, 2007 · This could precipitate a pharmacodynamic interaction known as serotonin syndrome, which is characterized by agitation, confusion, delirium, tachycardia, diaphoresis, …
Evidence-Based Approaches to Managing Nausea and Vomiting in …
When dopamine (D 1) receptors in the CNS are antagonized, the normal impulses in the basal ganglia and extrapyramidal system that control involuntary motion, balance, posture, and …
New Guidance on Antipsychotic Choice - Medscape
Jul 19, 2019 · Choosing the best antipsychotic for individual patients with schizophrenia is challenging. A new meta-analysis seeks to inform that choice by ranking 32 antipsychotics on …
FDA OKs First-in-Class Antipsychotic for Schizophrenia - Medscape
Sep 27, 2024 · The US Food and Drug Administration (FDA) has approved Cobenfy (Bristol Myers Squibb), a first-in-class antipsychotic approved for schizophrenia.The drug targets …
Depression, Extrapyramidal Symptoms, Dementia and an
English Edition. Medscape. English; Deutsch; Español; Français; Português; Univadis